(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SLC16A1 mRNA] CTD PMID:31150632 (1->4)-beta-D-glucan multiple interactions ISO Slc16a1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC16A1 mRNA CTD PMID:36331819 (S)-mandelic acid multiple interactions EXP 6480464 mandelic acid inhibits the reaction [SLC16A1 protein results in increased transport of Benzoic Acid] CTD PMID:10714609 (S)-naringenin multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 naringenin inhibits the reaction [SLC16A1 protein results in increased uptake of Benzoic Acid] CTD PMID:17976262 (S)-naringenin multiple interactions EXP 6480464 [naringenin results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate CTD PMID:17108059 1,2-dimethylhydrazine decreases expression ISO Slc16a1 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of SLC16A1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO Slc16a1 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC16A1 mRNA CTD PMID:22206623 1,4-dithiothreitol multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 Dithiothreitol inhibits the reaction [SLC16A1 protein results in increased uptake of Lactic Acid] CTD PMID:15804185 17alpha-ethynylestradiol affects expression ISO Slc16a1 (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of SLC16A1 mRNA CTD PMID:17555576 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of SLC16A1 mRNA CTD PMID:26865667 17alpha-ethynylestradiol multiple interactions ISO Slc16a1 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC16A1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO Slc16a1 (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of SLC16A1 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of SLC16A1 mRNA and EGF protein promotes the reaction [Estradiol results in increased expression of SLC16A1 mRNA] CTD PMID:19619570 and PMID:24758408 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of SLC16A1 mRNA CTD PMID:32145629 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLC16A1 mRNA CTD PMID:32741896 17beta-estradiol increases expression ISO SLC16A1 (Homo sapiens) 6480464 Estradiol results in increased expression of SLC16A1 mRNA CTD PMID:19619570 more ... 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLC16A1 mRNA CTD PMID:32741896 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of SLC16A1 mRNA and [Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of SLC16A1 mRNA CTD PMID:19619570 and PMID:19684285 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Slc16a1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC16A1 mRNA CTD PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC16A1 mRNA CTD PMID:16054898 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Slc16a1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of SLC16A1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of SLC16A1 mRNA] CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO SLC16A1 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC16A1 mRNA CTD PMID:19619570 and PMID:19684285 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Slc16a1 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC16A1 mRNA CTD PMID:17942748 2,4-dinitrophenol multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 2 and 4-Dinitrophenol inhibits the reaction [SLC16A1 protein results in increased uptake of Lactic Acid] CTD PMID:15804185 2-deoxy-D-glucose multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 [Lactic Acid co-treated with Deoxyglucose] promotes the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC16A1 protein] CTD PMID:36336208 2-hydroxypropanoic acid multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 2 more ... CTD PMID:15804185 more ... 2-hydroxypropanoic acid increases uptake ISO SLC16A1 (Homo sapiens) 6480464 SLC16A1 protein results in increased uptake of Lactic Acid CTD PMID:15804185 and PMID:25719685 2-hydroxypropanoic acid increases import EXP 6480464 SLC16A1 protein results in increased import of Lactic Acid CTD PMID:10579682 2-hydroxypropanoic acid increases transport EXP 6480464 SLC16A1 protein results in increased transport of Lactic Acid CTD PMID:10714609 and PMID:19929853 2-hydroxypropanoic acid multiple interactions EXP 6480464 AR C155858 inhibits the reaction [SLC16A1 protein results in increased transport of Lactic Acid] and Protons promotes the reaction [SLC16A1 protein results in increased import of Lactic Acid] CTD PMID:10579682 and PMID:19929853 2-hydroxypropanoic acid increases uptake EXP 6480464 SLC16A1 protein results in increased uptake of Lactic Acid CTD PMID:11785685 2-oxobutanoic acid multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 alpha-ketobutyric acid inhibits the reaction [SLC16A1 protein results in increased uptake of Butyrates] CTD PMID:19023563 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:19692669 and PMID:23196670 3,4-methylenedioxymethamphetamine multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine affects the reaction [SLC16A1 protein results in increased uptake of Butyrates] CTD PMID:19023563 3,4-methylenedioxymethamphetamine increases expression ISO Slc16a1 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of SLC16A1 mRNA CTD PMID:20188158 3,4-methylenedioxymethamphetamine increases expression ISO SLC16A1 (Homo sapiens) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of SLC16A1 mRNA CTD PMID:19023563 3-bromopyruvic acid multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 SLC16A1 protein results in increased uptake of and results in increased susceptibility to bromopyruvate CTD PMID:23202129 3-methyladenine multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 3-methyladenine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC16A1 protein] CTD PMID:36336208 4,4'-diaminodiphenylmethane increases expression ISO Slc16a1 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of SLC16A1 mRNA CTD PMID:18648102 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in decreased expression of SLC16A1 mRNA CTD PMID:30723492 4,4'-sulfonyldiphenol increases expression ISO Slc16a1 (Mus musculus) 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of SLC16A1 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol increases expression ISO SLC16A1 (Homo sapiens) 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of SLC16A1 protein CTD PMID:34186270 5-aza-2'-deoxycytidine multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 [Decitabine co-treated with trichostatin A] results in increased expression of SLC16A1 mRNA CTD PMID:20678512 5-aza-2'-deoxycytidine increases expression ISO SLC16A1 (Homo sapiens) 6480464 Decitabine results in increased expression of SLC16A1 mRNA CTD PMID:20678512 5-aza-2'-deoxycytidine affects methylation ISO SLC16A1 (Homo sapiens) 6480464 Decitabine affects the methylation of SLC16A1 gene CTD PMID:17630775 5-fluorouracil decreases expression ISO SLC16A1 (Homo sapiens) 6480464 Fluorouracil results in decreased expression of SLC16A1 mRNA CTD PMID:16709241 5-Nitro-2-(3-phenylpropylamino)benzoic acid multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [SLC16A1 protein results in increased uptake of Butyrates] CTD PMID:19023563 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of SLC16A1 mRNA CTD PMID:22504374 9-cis-retinoic acid decreases expression ISO SLC16A1 (Homo sapiens) 6480464 Alitretinoin results in decreased expression of SLC16A1 mRNA CTD PMID:15982314 acetaldehyde multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 Acetaldehyde inhibits the reaction [SLC16A1 protein results in increased uptake of Butyrates] CTD PMID:19023563 acetate ester multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 Acetates inhibits the reaction [SLC16A1 protein results in increased uptake of Butyrates] CTD PMID:19023563 acetic acid increases import EXP 6480464 SLC16A1 protein results in increased import of Acetic Acid CTD PMID:10579682 acetic acid multiple interactions EXP 6480464 Acetic Acid inhibits the reaction [SLC16A1 protein results in increased transport of Benzoic Acid] CTD PMID:10714609 acetylsalicylic acid multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 Aspirin affects the reaction [SLC16A1 protein results in increased uptake of Butyrates] CTD PMID:19023563 acetylsalicylic acid decreases expression ISO SLC16A1 (Homo sapiens) 6480464 Aspirin results in decreased expression of SLC16A1 mRNA CTD PMID:11906190 alachlor increases expression EXP 6480464 alachlor results in increased expression of SLC16A1 mRNA CTD PMID:12419858 all-trans-4-oxoretinoic acid decreases expression ISO SLC16A1 (Homo sapiens) 6480464 4-oxoretinoic acid results in decreased expression of SLC16A1 mRNA CTD PMID:15982314 all-trans-retinoic acid decreases expression ISO SLC16A1 (Homo sapiens) 6480464 Tretinoin metabolite results in decreased expression of SLC16A1 mRNA and Tretinoin results in decreased expression of SLC16A1 mRNA CTD PMID:15498508 more ... alpha-hexachlorocyclohexane affects expression EXP 6480464 alpha-hexachlorocyclohexane affects the expression of SLC16A1 mRNA CTD PMID:16940010 alpha-hexachlorocyclohexane increases expression EXP 6480464 alpha-hexachlorocyclohexane results in increased expression of SLC16A1 mRNA CTD PMID:16940010 alpha-hexachlorocyclohexane decreases expression EXP 6480464 alpha-hexachlorocyclohexane results in decreased expression of SLC16A1 mRNA CTD PMID:16940010 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SLC16A1 mRNA CTD PMID:16483693 antirheumatic drug increases expression ISO SLC16A1 (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of SLC16A1 mRNA CTD PMID:24449571 apigenin multiple interactions EXP 6480464 [Apigenin results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate CTD PMID:17108059 aristolochic acid A decreases expression ISO SLC16A1 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of SLC16A1 mRNA CTD PMID:33212167 benzalkonium chloride increases expression ISO Slc16a1 (Mus musculus) 6480464 Benzalkonium Compounds results in increased expression of SLC16A1 mRNA CTD PMID:31199489 benzene multiple interactions EXP 6480464 [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of SLC16A1 mRNA CTD PMID:17905399 benzo[a]pyrene decreases expression ISO Slc16a1 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of SLC16A1 mRNA CTD PMID:19770486 benzo[a]pyrene affects methylation ISO SLC16A1 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of SLC16A1 promoter CTD PMID:27901495 benzo[a]pyrene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with 1 more ... CTD PMID:18711122 benzo[b]fluoranthene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of SLC16A1 mRNA CTD PMID:18711122 benzoic acid multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 [MYC protein results in increased expression of SLC16A1 protein] which results in increased import of Benzoic Acid more ... CTD PMID:15804185 more ... benzoic acid increases transport EXP 6480464 SLC16A1 protein results in increased transport of Benzoic Acid CTD PMID:10714609 benzoic acid increases import EXP 6480464 SLC16A1 protein results in increased import of Benzoic Acid CTD PMID:10579682 benzoic acid increases export EXP 6480464 SLC16A1 protein results in increased export of Benzoic Acid CTD PMID:10579682 benzoic acid increases uptake ISO SLC16A1 (Homo sapiens) 6480464 SLC16A1 protein results in increased uptake of Benzoic Acid CTD PMID:17976262 benzoic acid multiple interactions EXP 6480464 Acetic Acid inhibits the reaction [SLC16A1 protein results in increased transport of Benzoic Acid] more ... CTD PMID:10579682 and PMID:10714609 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of SLC16A1 mRNA CTD PMID:18164116 biochanin A multiple interactions EXP 6480464 [biochanin A results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate CTD PMID:17108059 bis(2-chloroethyl) sulfide affects expression EXP 6480464 Mustard Gas affects the expression of SLC16A1 mRNA CTD PMID:15651846 bisphenol A decreases expression ISO SLC16A1 (Homo sapiens) 6480464 bisphenol A results in decreased expression of SLC16A1 mRNA CTD PMID:20678512 bisphenol A increases expression ISO SLC16A1 (Homo sapiens) 6480464 bisphenol A results in increased expression of SLC16A1 protein CTD PMID:34186270 bisphenol A increases expression ISO Slc16a1 (Mus musculus) 6480464 bisphenol A results in increased expression of SLC16A1 mRNA CTD PMID:32156529 bisphenol A decreases methylation ISO SLC16A1 (Homo sapiens) 6480464 bisphenol A results in decreased methylation of SLC16A1 gene CTD PMID:31601247 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC16A1 mRNA and bisphenol A results in decreased expression of SLC16A1 protein CTD PMID:27364615 more ... bisphenol A multiple interactions EXP 6480464 fulvestrant inhibits the reaction [bisphenol A results in decreased expression of SLC16A1 protein] CTD PMID:27364615 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SLC16A1 mRNA CTD PMID:15901920 more ... Bisphenol B increases expression ISO SLC16A1 (Homo sapiens) 6480464 bisphenol B results in increased expression of SLC16A1 protein CTD PMID:34186270 bisphenol F increases expression ISO Slc16a1 (Mus musculus) 6480464 bisphenol F results in increased expression of SLC16A1 mRNA CTD PMID:30951980 butyric acid increases import EXP 6480464 SLC16A1 protein results in increased import of Butyric Acid CTD PMID:10579682 butyric acid multiple interactions EXP 6480464 Butyric Acid inhibits the reaction [SLC16A1 protein results in increased transport of Benzoic Acid] CTD PMID:10714609 cadmium atom increases expression ISO SLC16A1 (Homo sapiens) 6480464 Cadmium results in increased expression of SLC16A1 mRNA CTD PMID:23369406 cadmium atom multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 3-methyladenine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC16A1 protein] more ... CTD PMID:35301059 and PMID:36336208 cadmium dichloride multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 3-methyladenine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC16A1 protein] more ... CTD PMID:35301059 and PMID:36336208 caffeine multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 Caffeine affects the reaction [SLC16A1 protein results in increased uptake of Butyrates] CTD PMID:19023563 caffeine increases phosphorylation ISO SLC16A1 (Homo sapiens) 6480464 Caffeine results in increased phosphorylation of SLC16A1 protein CTD PMID:35688186 caffeine increases expression ISO SLC16A1 (Homo sapiens) 6480464 Caffeine results in increased expression of SLC16A1 mRNA CTD PMID:19023563 cantharidin decreases expression ISO Slc16a1 (Mus musculus) 6480464 Cantharidin results in decreased expression of SLC16A1 mRNA CTD PMID:36907384 choline multiple interactions ISO Slc16a1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of SLC16A1 and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SLC16A1 gene CTD PMID:20938992 chrysin multiple interactions EXP 6480464 [chrysin results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate CTD PMID:17108059 ciprofibrate increases expression ISO Slc16a1 (Mus musculus) 6480464 ciprofibrate results in increased expression of SLC16A1 mRNA CTD PMID:12771043 cisplatin multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 [Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of SLC16A1 mRNA and Cisplatin inhibits the reaction [Piroxicam results in increased expression of SLC16A1 mRNA] CTD PMID:21858171 and PMID:30871063 clofibrate multiple interactions EXP 6480464 [Clofibrate results in increased activity of PPARA protein] which results in increased expression of SLC16A1 mRNA CTD PMID:18375207 clofibrate increases expression ISO Slc16a1 (Mus musculus) 6480464 Clofibrate results in increased expression of SLC16A1 mRNA CTD PMID:23811191 Clofop multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 [fenofibric acid binds to PPARA protein] which results in increased expression of SLC16A1 mRNA CTD PMID:16197558 curcumin decreases expression ISO Slc16a1 (Mus musculus) 6480464 Curcumin results in decreased expression of SLC16A1 protein CTD PMID:21397623 cycloheximide multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 [Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of SLC16A1 mRNA CTD PMID:19684285 cyclosporin A increases expression ISO SLC16A1 (Homo sapiens) 6480464 Cyclosporine results in increased expression of SLC16A1 mRNA CTD PMID:20106945 cyclosporin A decreases expression ISO SLC16A1 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of SLC16A1 mRNA CTD PMID:25562108 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of SLC16A1 mRNA CTD PMID:21865292 daidzein multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of SLC16A1 mRNA CTD PMID:27424125 daidzein 7-O-beta-D-glucoside multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of SLC16A1 mRNA CTD PMID:27424125 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of SLC16A1 mRNA CTD PMID:23640034 deoxynivalenol increases phosphorylation ISO Slc16a1 (Mus musculus) 6480464 deoxynivalenol results in increased phosphorylation of SLC16A1 protein CTD PMID:23811945 dibenz[a,h]anthracene multiple interactions EXP 6480464 [1 more ... CTD PMID:18711122 dibenzo[a,l]pyrene multiple interactions EXP 6480464 [1 more ... CTD PMID:18711122 dichlorine multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in increased expression of SLC16A1 mRNA CTD PMID:18636392 dichloroacetic acid decreases expression ISO Slc16a1 (Mus musculus) 6480464 Dichloroacetic Acid results in decreased expression of SLC16A1 mRNA and Dichloroacetic Acid results in decreased expression of SLC16A1 protein CTD PMID:22705712 dieldrin decreases expression EXP 6480464 Dieldrin results in decreased expression of SLC16A1 mRNA CTD PMID:23153324 diosmetin multiple interactions EXP 6480464 [diosmetin results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate CTD PMID:17108059 dioxygen increases expression ISO Slc16a1 (Mus musculus) 6480464 Oxygen deficiency results in increased expression of SLC16A1 mRNA CTD PMID:22629407 dioxygen multiple interactions ISO Slc16a1 (Mus musculus) 6480464 Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of SLC16A1 mRNA] CTD PMID:22629407 diquat increases expression ISO Slc16a1 (Mus musculus) 6480464 Diquat results in increased expression of SLC16A1 mRNA and Diquat results in increased expression of SLC16A1 protein CTD PMID:36851058 diuron decreases expression EXP 6480464 Diuron results in decreased expression of SLC16A1 mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO SLC16A1 (Homo sapiens) 6480464 Doxorubicin results in increased expression of SLC16A1 mRNA CTD PMID:29803840 entinostat increases expression ISO SLC16A1 (Homo sapiens) 6480464 entinostat results in increased expression of SLC16A1 mRNA CTD PMID:26272509 entinostat multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC16A1 mRNA CTD PMID:27188386 epoxiconazole increases expression ISO Slc16a1 (Mus musculus) 6480464 epoxiconazole results in increased expression of SLC16A1 mRNA CTD PMID:35436446 ethyl methanesulfonate decreases expression ISO SLC16A1 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in decreased expression of SLC16A1 mRNA CTD PMID:23649840 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of SLC16A1 mRNA CTD PMID:30307764 fisetin multiple interactions EXP 6480464 [fisetin results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate CTD PMID:17108059 fluoranthene multiple interactions EXP 6480464 [1 more ... CTD PMID:18711122 folic acid multiple interactions ISO Slc16a1 (Mus musculus) 6480464 [1 more ... CTD PMID:20938992 and PMID:22206623 folic acid decreases expression ISO Slc16a1 (Mus musculus) 6480464 Folic Acid results in decreased expression of SLC16A1 mRNA CTD PMID:25629700 folic acid decreases expression ISO SLC16A1 (Homo sapiens) 6480464 Folic Acid deficiency results in decreased expression of SLC16A1 mRNA CTD PMID:20465997 formaldehyde decreases expression ISO SLC16A1 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of SLC16A1 mRNA CTD PMID:23649840 formic acid multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 formic acid binds to and results in increased stability of and affects the activity of SLC16A1 protein CTD PMID:29851333 fulvestrant multiple interactions EXP 6480464 fulvestrant inhibits the reaction [bisphenol A results in decreased expression of SLC16A1 protein] CTD PMID:27364615 geldanamycin increases expression ISO SLC16A1 (Homo sapiens) 6480464 geldanamycin results in increased expression of SLC16A1 mRNA CTD PMID:26705709 genistein increases expression EXP 6480464 Genistein results in increased expression of SLC16A1 mRNA CTD PMID:15901920 genistein multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of SLC16A1 mRNA CTD PMID:27424125 genistein increases expression ISO SLC16A1 (Homo sapiens) 6480464 Genistein results in increased expression of SLC16A1 mRNA CTD PMID:26865667 genistein multiple interactions EXP 6480464 [Genistein results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate CTD PMID:17108059 genistein 7-O-beta-D-glucoside multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of SLC16A1 mRNA CTD PMID:27424125 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of SLC16A1 mRNA CTD PMID:22061828 glafenine increases expression EXP 6480464 Glafenine results in increased expression of SLC16A1 mRNA CTD PMID:24136188 glycitein multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of SLC16A1 mRNA CTD PMID:27424125 glycitin multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of SLC16A1 mRNA CTD PMID:27424125 heptachlor decreases expression EXP 6480464 Heptachlor results in decreased expression of SLC16A1 mRNA CTD PMID:23153324 hesperetin multiple interactions EXP 6480464 [hesperetin results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate CTD PMID:17108059 hydrogen peroxide affects expression ISO SLC16A1 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of SLC16A1 mRNA CTD PMID:20044591 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of SLC16A1 mRNA CTD PMID:21396975 indometacin multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 Indomethacin inhibits the reaction [SLC16A1 protein results in increased uptake of Butyrates] CTD PMID:19023563 indometacin decreases expression ISO SLC16A1 (Homo sapiens) 6480464 Indomethacin results in decreased expression of SLC16A1 mRNA CTD PMID:16984733 isotretinoin decreases expression ISO SLC16A1 (Homo sapiens) 6480464 Isotretinoin results in decreased expression of SLC16A1 mRNA CTD PMID:15982314 ivermectin decreases expression ISO SLC16A1 (Homo sapiens) 6480464 Ivermectin results in decreased expression of SLC16A1 protein CTD PMID:32959892 josamycin affects response to substance ISO SLC16A1 (Homo sapiens) 6480464 SLC16A1 protein affects the susceptibility to Josamycin CTD PMID:31915244 kaempferol multiple interactions EXP 6480464 [kaempferol results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate CTD PMID:17108059 kaempferol multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 kaempferol inhibits the reaction [SLC16A1 protein results in increased uptake of Lactic Acid] CTD PMID:25719685 L-1,4-dithiothreitol multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 Dithiothreitol inhibits the reaction [SLC16A1 protein results in increased uptake of Lactic Acid] CTD PMID:15804185 L-methionine multiple interactions ISO Slc16a1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of SLC16A1 and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SLC16A1 gene CTD PMID:20938992 luteolin multiple interactions EXP 6480464 [[Luteolin co-treated with Phloretin] results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate and [Luteolin results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate CTD PMID:17108059 mandelic acid multiple interactions EXP 6480464 mandelic acid inhibits the reaction [SLC16A1 protein results in increased transport of Benzoic Acid] CTD PMID:10714609 methamphetamine increases expression ISO Slc16a1 (Mus musculus) 6480464 Methamphetamine results in increased expression of SLC16A1 mRNA CTD PMID:36914120 methimazole increases expression EXP 6480464 Methimazole results in increased expression of SLC16A1 mRNA CTD PMID:22504374 methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of SLC16A1 gene CTD PMID:35440735 methyl methanesulfonate decreases expression ISO SLC16A1 (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of SLC16A1 mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO SLC16A1 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of SLC16A1 mRNA CTD PMID:23179753 and PMID:27188386 methylmercury(1+) multiple interactions EXP 6480464 [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of SLC16A1 mRNA CTD PMID:17905399 mirex decreases expression EXP 6480464 Mirex results in decreased expression of SLC16A1 mRNA CTD PMID:23153324 morin multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 morin inhibits the reaction [SLC16A1 protein results in increased uptake of Benzoic Acid] CTD PMID:17976262 morin multiple interactions EXP 6480464 [morin results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate CTD PMID:17108059 motexafin gadolinium multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of SLC16A1 mRNA] CTD PMID:16357179 motexafin gadolinium increases expression ISO SLC16A1 (Homo sapiens) 6480464 motexafin gadolinium results in increased expression of SLC16A1 mRNA CTD PMID:16357179 N-ethylmaleimide multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 Ethylmaleimide inhibits the reaction [SLC16A1 protein results in increased uptake of Lactic Acid] CTD PMID:15804185 N-nitrosodiethylamine increases expression ISO Slc16a1 (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of SLC16A1 mRNA CTD PMID:12771043 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of SLC16A1 mRNA CTD PMID:19638242 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of SLC16A1 mRNA CTD PMID:18164116 nickel atom increases expression ISO SLC16A1 (Homo sapiens) 6480464 Nickel results in increased expression of SLC16A1 mRNA CTD PMID:24768652 nicotinic acid increases import EXP 6480464 SLC16A1 protein results in increased import of Niacin CTD PMID:10579682 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of SLC16A1 mRNA and nitrofen results in decreased expression of SLC16A1 protein CTD PMID:26996590 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of SLC16A1 mRNA CTD PMID:33484710 ouabain multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 Ouabain inhibits the reaction [SLC16A1 protein results in increased uptake of Lactic Acid] CTD PMID:15804185 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SLC16A1 mRNA CTD PMID:25729387 oxycodone decreases expression EXP 6480464 Oxycodone results in decreased expression of SLC16A1 mRNA CTD PMID:23439660 ozone multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in increased expression of SLC16A1 mRNA CTD PMID:18636392 ozone increases phosphorylation EXP 6480464 Ozone results in increased phosphorylation of SLC16A1 protein CTD PMID:33146391 ozone decreases expression EXP 6480464 Ozone results in decreased expression of SLC16A1 protein CTD PMID:33146391 p-chloromercuribenzenesulfonic acid multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 4-Chloromercuribenzenesulfonate inhibits the reaction [SLC16A1 protein results in increased uptake of Lactic Acid] CTD PMID:15804185 p-chloromercuribenzoic acid multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 p-Chloromercuribenzoic Acid inhibits the reaction [SLC16A1 protein results in increased uptake of Butyrates] and p-Chloromercuribenzoic Acid inhibits the reaction [SLC16A1 protein results in increased uptake of Lactic Acid] CTD PMID:15804185 and PMID:19023563 panobinostat multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC16A1 mRNA CTD PMID:27188386 panobinostat increases expression ISO SLC16A1 (Homo sapiens) 6480464 panobinostat results in increased expression of SLC16A1 mRNA CTD PMID:26272509 paracetamol affects expression ISO Slc16a1 (Mus musculus) 6480464 Acetaminophen affects the expression of SLC16A1 mRNA CTD PMID:17562736 paracetamol increases expression ISO SLC16A1 (Homo sapiens) 6480464 Acetaminophen results in increased expression of SLC16A1 mRNA CTD PMID:29067470 paraquat increases expression EXP 6480464 Paraquat results in increased expression of SLC16A1 mRNA and Paraquat results in increased expression of SLC16A1 protein CTD PMID:24521700 and PMID:32680482 perfluorononanoic acid increases expression ISO SLC16A1 (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in increased expression of SLC16A1 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of SLC16A1 mRNA CTD PMID:19162173 perfluorooctane-1-sulfonic acid multiple interactions ISO Slc16a1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC16A1 mRNA CTD PMID:36331819 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of SLC16A1 mRNA CTD PMID:19162173 phloretin multiple interactions EXP 6480464 [[Luteolin co-treated with Phloretin] results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate and [Phloretin results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate CTD PMID:17108059 phosphonoformic acid increases import EXP 6480464 SLC16A1 protein results in increased import of Foscarnet CTD PMID:10579682 phosphonoformic acid multiple interactions EXP 6480464 Foscarnet inhibits the reaction [SLC16A1 protein results in increased transport of Benzoic Acid] CTD PMID:10714609 pirinixic acid multiple interactions ISO Slc16a1 (Mus musculus) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SLC16A1 mRNA and PPARA protein promotes the reaction [pirinixic acid results in increased expression of SLC16A1 mRNA] CTD PMID:19710929 and PMID:20059764 pirinixic acid increases expression ISO Slc16a1 (Mus musculus) 6480464 pirinixic acid results in increased expression of SLC16A1 mRNA CTD PMID:18301758 more ... pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of SLC16A1 mRNA CTD PMID:19162173 pirinixic acid multiple interactions EXP 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SLC16A1 mRNA CTD PMID:18375207 piroxicam multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 Cisplatin inhibits the reaction [Piroxicam results in increased expression of SLC16A1 mRNA] CTD PMID:21858171 piroxicam increases expression ISO SLC16A1 (Homo sapiens) 6480464 Piroxicam results in increased expression of SLC16A1 mRNA CTD PMID:21858171 potassium chromate increases expression ISO SLC16A1 (Homo sapiens) 6480464 potassium chromate(VI) results in increased expression of SLC16A1 mRNA CTD PMID:22714537 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of SLC16A1 mRNA CTD PMID:19162173 progesterone increases expression EXP 6480464 Progesterone results in increased expression of SLC16A1 mRNA CTD PMID:20726854 propionic acid increases import EXP 6480464 SLC16A1 protein results in increased import of propionic acid CTD PMID:10579682 propionic acid multiple interactions EXP 6480464 propionic acid inhibits the reaction [SLC16A1 protein results in increased transport of Benzoic Acid] CTD PMID:10714609 pyruvic acid multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 Pyruvic Acid inhibits the reaction [SLC16A1 protein results in increased uptake of Butyrates] and Pyruvic Acid inhibits the reaction [SLC16A1 protein results in increased uptake of Lactic Acid] CTD PMID:15804185 and PMID:19023563 quercetin multiple interactions EXP 6480464 [Quercetin results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate CTD PMID:17108059 quercetin multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 Quercetin inhibits the reaction [SLC16A1 protein results in increased uptake of Benzoic Acid] CTD PMID:17976262 rac-lactic acid increases uptake EXP 6480464 SLC16A1 protein results in increased uptake of Lactic Acid CTD PMID:11785685 rac-lactic acid increases import EXP 6480464 SLC16A1 protein results in increased import of Lactic Acid CTD PMID:10579682 rac-lactic acid increases transport EXP 6480464 SLC16A1 protein results in increased transport of Lactic Acid CTD PMID:10714609 and PMID:19929853 rac-lactic acid multiple interactions EXP 6480464 AR C155858 inhibits the reaction [SLC16A1 protein results in increased transport of Lactic Acid] and Protons promotes the reaction [SLC16A1 protein results in increased import of Lactic Acid] CTD PMID:10579682 and PMID:19929853 rac-lactic acid increases uptake ISO SLC16A1 (Homo sapiens) 6480464 SLC16A1 protein results in increased uptake of Lactic Acid CTD PMID:15804185 and PMID:25719685 rac-lactic acid multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 2 more ... CTD PMID:15804185 more ... resveratrol increases expression EXP 6480464 resveratrol results in increased expression of SLC16A1 mRNA CTD PMID:19228061 resveratrol multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of SLC16A1 mRNA CTD PMID:23557933 rotenone affects expression EXP 6480464 Rotenone affects the expression of SLC16A1 mRNA CTD PMID:28374803 salicylic acid multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 Salicylic Acid inhibits the reaction [SLC16A1 protein results in increased uptake of Lactic Acid] CTD PMID:15804185 salicylic acid multiple interactions EXP 6480464 Salicylic Acid inhibits the reaction [SLC16A1 protein results in increased transport of Benzoic Acid] CTD PMID:10714609 SB 431542 multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silibinin multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 Silybin inhibits the reaction [SLC16A1 protein results in increased uptake of Benzoic Acid] CTD PMID:17976262 sirolimus decreases expression EXP 6480464 Sirolimus results in decreased expression of SLC16A1 mRNA CTD PMID:21865292 sodium arsenite increases expression ISO SLC16A1 (Homo sapiens) 6480464 sodium arsenite results in increased expression of SLC16A1 mRNA CTD PMID:12760830 and PMID:17879257 sodium arsenite decreases expression ISO SLC16A1 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of SLC16A1 mRNA CTD PMID:28595984 and PMID:34032870 sodium azide multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 Sodium Azide inhibits the reaction [SLC16A1 protein results in increased uptake of Lactic Acid] CTD PMID:15804185 Soman increases expression EXP 6480464 Soman results in increased expression of SLC16A1 mRNA CTD PMID:19281266 sunitinib decreases expression ISO SLC16A1 (Homo sapiens) 6480464 Sunitinib results in decreased expression of SLC16A1 mRNA CTD PMID:31533062 tacrolimus hydrate decreases expression EXP 6480464 Tacrolimus results in decreased expression of SLC16A1 mRNA CTD PMID:21865292 tamibarotene affects expression ISO SLC16A1 (Homo sapiens) 6480464 tamibarotene affects the expression of SLC16A1 mRNA CTD PMID:15498508 tamoxifen affects expression ISO Slc16a1 (Mus musculus) 6480464 Tamoxifen affects the expression of SLC16A1 mRNA CTD PMID:17555576 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLC16A1 mRNA CTD PMID:32741896 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of SLC16A1 mRNA CTD PMID:31150632 tetrachloromethane increases expression ISO Slc16a1 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of SLC16A1 mRNA CTD PMID:31919559 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SLC16A1 mRNA] CTD PMID:31150632 theophylline multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 Theophylline inhibits the reaction [SLC16A1 protein results in increased uptake of Butyrates] CTD PMID:19023563 thimerosal decreases expression ISO SLC16A1 (Homo sapiens) 6480464 Thimerosal results in decreased expression of SLC16A1 mRNA CTD PMID:27188386 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of SLC16A1 mRNA CTD PMID:23411599 and PMID:34492290 topiramate increases expression EXP 6480464 topiramate results in increased expression of SLC16A1 mRNA CTD PMID:16979414 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SLC16A1 mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of SLC16A1 mRNA CTD PMID:25729387 Tributyltin oxide increases phosphorylation ISO Slc16a1 (Mus musculus) 6480464 bis(tri-n-butyltin)oxide results in increased phosphorylation of SLC16A1 protein CTD PMID:22174045 trichloroethene multiple interactions EXP 6480464 [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of SLC16A1 mRNA CTD PMID:17905399 trichostatin A multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 [Decitabine co-treated with trichostatin A] results in increased expression of SLC16A1 mRNA more ... CTD PMID:20678512 and PMID:27188386 trichostatin A increases expression ISO SLC16A1 (Homo sapiens) 6480464 trichostatin A results in increased expression of SLC16A1 mRNA CTD PMID:20678512 more ... triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of SLC16A1 mRNA CTD PMID:30589522 Triptolide increases expression ISO Slc16a1 (Mus musculus) 6480464 triptolide results in increased expression of SLC16A1 mRNA CTD PMID:32835833 triptonide increases expression ISO Slc16a1 (Mus musculus) 6480464 triptonide results in increased expression of SLC16A1 mRNA CTD PMID:33045310 urethane increases expression ISO Slc16a1 (Mus musculus) 6480464 Urethane results in increased expression of SLC16A1 CTD PMID:26524634 valproic acid affects expression ISO SLC16A1 (Homo sapiens) 6480464 Valproic Acid affects the expression of SLC16A1 mRNA CTD PMID:25979313 valproic acid multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC16A1 mRNA CTD PMID:27188386 valproic acid increases expression ISO SLC16A1 (Homo sapiens) 6480464 Valproic Acid results in increased expression of SLC16A1 mRNA CTD PMID:23179753 more ... vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of SLC16A1 mRNA CTD PMID:23034163 zidovudine decreases expression ISO SLC16A1 (Homo sapiens) 6480464 Zidovudine results in decreased expression of SLC16A1 mRNA CTD PMID:24292225 zinc acetate multiple interactions ISO SLC16A1 (Homo sapiens) 6480464 motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of SLC16A1 mRNA] CTD PMID:16357179 zinc acetate increases expression ISO SLC16A1 (Homo sapiens) 6480464 Zinc Acetate results in increased expression of SLC16A1 mRNA CTD PMID:16357179 zoledronic acid increases expression ISO SLC16A1 (Homo sapiens) 6480464 zoledronic acid results in increased expression of SLC16A1 mRNA CTD PMID:20977926
